The atypical 16p11.2 deletion: A not so atypical microdeletion syndrome?

One of the recently recognized microdeletion syndromes is the 16p11.2 deletion syndrome (593 kb; ∼29.5 Mb to ∼30.1 Mb), associated with developmental delay, autism spectrum disorder, epilepsy, and obesity. Less frequently reported is a smaller 220 kb deletion, adjacent and distal to this 16p11.2 deletion, which has been referred to as the atypical 16p11.2 deletion (220 kb; ∼28.74 Mb to ∼28.95 Mb). We describe three patients with this deletion and update the manifestations in two sibs who have been described as possibly new entity in this Journal in 1997 [Bakker and Hennekam (1997); Am J Med Genet 70:312–314] and were recently found to have the “atypical 16p11.2 deletion” as well. Patients show a developmental delay, behavioral problems, and unusual facial morphology (prominent forehead, downslanted, and narrow palpebral fissures), and some are obese. We suggest that this “atypical” deletion may turn out to become a microdeletion syndrome that will be recognizable in the future, or at least to show a phenotype that is recognizable in retrospect. As it may no longer be so “atypical,” we suggest renaming the entity “distal 16p11.2 deletion,” to distinguish it from the common proximal 16p11.2 deletion. © 2011 Wiley‐Liss, Inc.

[1]  Deborah L. Levy,et al.  A recurrent 16p12.1 microdeletion suggests a two-hit model for severe developmental delay , 2010, Nature Genetics.

[2]  Manuel Corpas,et al.  DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. , 2009, American journal of human genetics.

[3]  Kenny Q. Ye,et al.  Strong Association of De Novo Copy Number Mutations with Autism , 2007, Science.

[4]  D. Pinto,et al.  Structural variation of chromosomes in autism spectrum disorder. , 2008, American journal of human genetics.

[5]  J. Fraumeni,et al.  Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women. , 2009, Blood.

[6]  S. Rezkalla,et al.  A novel microdeletion at 16p11.2 harbors candidate genes for aortic valve development, seizure disorder, and mild mental retardation , 2007, American journal of medical genetics. Part A.

[7]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[8]  J. Rosenfeld,et al.  Recurrent 200-kb deletions of 16p11.2 that include the SH2B1 gene are associated with developmental delay and obesity , 2010, Genetics in Medicine.

[9]  U. Surti,et al.  Discovery of a previously unrecognized microdeletion syndrome of 16p11.2–p12.2 , 2007, Nature Genetics.

[10]  E. Zackai,et al.  Evidence for a recurrent microdeletion at chromosome 16p11.2 associated with congenital anomalies of the kidney and urinary tract (CAKUT) and Hirschsprung disease , 2010, American journal of medical genetics. Part A.

[11]  A. Slavotinek Novel microdeletion syndromes detected by chromosome microarrays , 2008, Human Genetics.

[12]  J. Schuurs-Hoeijmakers,et al.  Extending the phenotype of recurrent rearrangements of 16p11.2: deletions in mentally retarded patients without autism and in normal individuals. , 2009, European journal of medical genetics.

[13]  A. Battaglia,et al.  Further characterization of the new microdeletion syndrome of 16p11.2–p12.2 , 2009, American journal of medical genetics. Part A.

[14]  Christian R Marshall,et al.  Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder , 2009, Journal of Medical Genetics.

[15]  P. Stankiewicz,et al.  Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size , 2009, Journal of Medical Genetics.

[16]  Yiping Shen,et al.  Cognitive and Behavioral Characterization of 16p11.2 Deletion Syndrome , 2010, Journal of developmental and behavioral pediatrics : JDBP.

[17]  Toshiyuki Yamamoto,et al.  A familial 593-kb microdeletion of 16p11.2 associated with mental retardation and hemivertebrae. , 2009, European journal of medical genetics.

[18]  P. Elliott,et al.  A novel highly-penetrant form of obesity due to microdeletions on chromosome 16p11.2 , 2009, Nature.

[19]  Robert T. Schultz,et al.  Autism genome-wide copy number variation reveals ubiquitin and neuronal genes , 2009, Nature.

[20]  Leslie G Biesecker,et al.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. , 2010, American journal of human genetics.

[21]  Joshua M. Korn,et al.  Association between microdeletion and microduplication at 16p11.2 and autism. , 2008, The New England journal of medicine.

[22]  D. Conrad,et al.  Recurrent 16p11.2 microdeletions in autism. , 2007, Human molecular genetics.

[23]  A. Hoischen,et al.  Mapping candidate regions and genes for congenital anomalies of the kidneys and urinary tract (CAKUT) by array-based comparative genomic hybridization. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  M. Hurles,et al.  Large, rare chromosomal deletions associated with severe early-onset obesity , 2010, Nature.